Using a national survey of sarcoma experts with an exceptionally high response rate, Wasif and colleagues1 present an interesting study designed to evaluate whether physician specialty influences adjuvant treatment recommendations in the multidisciplinary management of soft tissue sarcoma and the perceived benefit of these modalities. They reveal a specialty bias in treatment recommendations for soft tissue sarcoma of the extremities that provides unique insights into understanding the existing variation in treatment approaches for this relatively rare disease.
Sherman KL, Wayne JD, Bilimoria KY. Overcoming Specialty BiasAnother Important Reason for Multidisciplinary Management of Soft Tissue Sarcoma. JAMA Surg. 2013;148(7):640. doi:10.1001/jamasurg.2013.143